Danielle Simon
Payments from drug & device makers
Across 128 payments — averaging $26.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$318
- Genentech USA, Inc.$251
- AbbVie$239
- Merck$196
- Astellas Pharma US Inc$183
- Karyopharm Therapeutics Inc.$139
- plus $2K from 34 others
What the payments were for
- Food & beverage$3,10191%
- Education$2959%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $318 |
| Genentech USA, Inc. | 10 | $251 |
| AbbVie | 10 | $239 |
| Merck | 9 | $196 |
| Astellas Pharma US Inc | 6 | $183 |
| Karyopharm Therapeutics Inc. | 3 | $139 |
| Eisai Inc. | 7 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $130 |
| Array Biopharma Inc | 5 | $122 |
| Amgen | 1 | $120 |
| Stryker | 2 | $102 |
| Seagen Inc. | 1 | $99 |
| Regeneron Healthcare Solutions, Inc. | 5 | $90 |
| E.r. Squibb & Sons, L.L.C. | 3 | $86 |
| Boehringer Ingelheim | 3 | $82 |
| Novartis | 3 | $81 |
| Rigel Pharmaceuticals, Inc. | 4 | $79 |
| Daiichi Sankyo Inc. | 3 | $77 |
| Tersera Therapeutics LLC | 2 | $71 |
| Jazz Pharmaceuticals Inc. | 2 | $59 |
| Beone Medicines USA, Inc. | 2 | $55 |
| Lilly USA, LLC | 2 | $53 |
| Pfizer | 3 | $53 |
| Adaptive Biotechnologies Corporation | 2 | $52 |
| Bristol Myers Squibb | 2 | $52 |
| GSK | 2 | $50 |
| AVEO Pharmaceuticals, Inc. | 3 | $50 |
| Bayer | 2 | $47 |
| Exelixis Inc. | 2 | $45 |
| Johnson & Johnson | 2 | $45 |
| Coherus Oncology, Inc. | 2 | $34 |
| Syndax Pharmaceuticals, Inc. | 1 | $33 |
| Geron Corporation | 1 | $27 |
| Servier Pharmaceuticals LLC | 1 | $24 |
| Incyte Corporation | 1 | $22 |
| Sobi, Inc | 1 | $22 |
| ADC Therapeutics America, Inc. | 1 | $20 |
| Genmab U.S., Inc. | 1 | $18 |
| Acrotech Biopharma Inc. | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMDELLTRA (AMG 757)$120
- LUMAKRAS$120
- XPOVIO$102
How this compares
$3,396 in reported general payments places this provider in the 85th percentile of 4,392 family providers in Indiana.
Other family in Dyer
- Maria MarreroDyer$18K
- Michelle TerwilligerDyer$16K
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.